Skip to main content
Nanobiotix logo

Nanobiotix — Investor Relations & Filings

Ticker · NANO ISIN · FR0011341205 LEI · 969500667RSYIH8YL895 PA Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2020-12-15 Capital/Financing Update
Country FR France
Listing PA NANO

About Nanobiotix

https://www.nanobiotix.com/

Nanobiotix is a late-stage clinical biotechnology company pioneering a physics-based approach to cancer treatment through the development of nanotherapeutics. Its lead product candidate, NBTXR3, is a potential first-in-class radioenhancer designed to be injected directly into a tumor. When activated by radiotherapy, NBTXR3 amplifies the radiation dose within the tumor, aiming to destroy cancer cells more effectively without increasing exposure to surrounding healthy tissues. This process is also intended to prime an immune response to target metastatic tumors. The company is developing NBTXR3 for broad application across various solid tumors, with an initial focus on head, neck, and lung cancers through a global licensing agreement with Janssen Pharmaceutica NV.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Capital/Financing Update Classification · 98% confidence The document is a press release ("COMMUNIQUÉ DE PRESSE") announcing the final settlement and closing of a global offering (IPO/capital increase) on the Nasdaq, including the full exercise of the over-allotment option. It details the gross proceeds ($113.3 million) from the issuance of new American Depositary Shares (ADSs) and ordinary shares. This type of announcement, focusing on fundraising, capital structure changes, and the completion of a securities offering, directly aligns with the definition of a Capital/Financing Update. It is not an Annual Report (10-K), an Interim Report (IR), or a simple Earnings Release (ER). While it mentions the filing of a Form F-1 with the SEC, the document itself is the announcement of the financing event, making 'CAP' the most appropriate classification over a general 'RNS' or 'RPA'.
2020-12-15 French
Inside Information / Operations of the issuer (acquisitions, sales...)
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "*PRESS RELEASE*" and announces the "CLOSING OF GLOBAL OFFERING AND FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL ADSs". It details the gross proceeds, the listing on Nasdaq, the structure of the U.S. and European offerings, and the intended use of proceeds. This content directly relates to a financing activity, specifically an Initial Public Offering (IPO) closing and subsequent capital raise actions. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital market transaction.
2020-12-15 English
Franchissement de seuil
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" which translates to 'Declaration of crossing a threshold (Article L. 233-7 of the Commercial Code)'. It explicitly states that an individual (M. Laurent Lévy) crossed below the 5% threshold of voting rights in NANOBIOTIX on December 11, 2020. This type of filing, reporting changes in significant share ownership or voting rights thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is short and contains the core declaration, confirming it is the filing itself, not an announcement of a filing.
2020-12-14 French
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 98% confidence The document is a press release titled "NANOBIOTIX ANNONCE LA MISE A DISPOSITION D'UN PROSPECTUS DANS LE CADRE DE SON INTRODUCTION EN BOURSE SUR LE NASDAQ GLOBAL SELECT MARKET" (NANOBIOTIX ANNOUNCES THE AVAILABILITY OF A PROSPECTUS IN CONNECTION WITH ITS INITIAL PUBLIC OFFERING ON THE NASDAQ GLOBAL SELECT MARKET). It explicitly states that the AMF (Autorité des marchés financiers) approved a prospectus on December 11, 2020, for a public offering of new shares, including American Depositary Shares, related to its IPO on Nasdaq. The text details the components of the prospectus (universal registration document, amendments, offering circular, summary) and where to find them. This document is not the full financial report (10-K or IR) but an announcement regarding the availability of offering/listing documentation, which strongly aligns with the definition of a Capital/Financing Update (CAP) or, given the context of making offering documents available, potentially a Report Publication Announcement (RPA) if it were announcing a standard report. However, since the core subject is the IPO and the availability of the prospectus required for that capital raising event, 'CAP' is the most specific fit for the underlying corporate action. Given the focus on the prospectus approval and availability for a listing, 'CAP' (Capital/Financing Update) is the primary classification, although 'RPA' could also apply if the focus was purely on the publication act. Since the document is substantial and details the financing event itself (IPO), CAP is preferred over RPA, which is usually for routine report releases. The document is a formal announcement related to a major financing/listing event.
2020-12-11 French
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces the resumption of trading for the company's ordinary shares on Euronext Paris following a suspension related to a global offering and the start of trading for American Depositary Shares (ADSs) on Nasdaq. It discusses the mechanics of the offering, references previous regulatory filings (Universal Registration Document), and includes standard disclaimers about forward-looking statements and offering restrictions in various jurisdictions (EEA, France). This type of announcement, detailing a corporate action (listing/trading resumption related to a financing event) via a press release, is generally classified as a general regulatory announcement or a financing update. Since the core event is the resumption of trading after a global offering, it strongly relates to capital/financing activities (CAP). However, because it is a formal announcement of a corporate event that doesn't fit perfectly into the specific financial report categories (like 10-K, ER, IR), and it is a general regulatory communication, the most appropriate general category for such an announcement, especially when it pertains to market mechanics and regulatory compliance announcements, is Regulatory Filings (RNS), or potentially Capital/Financing Update (CAP). Given the context of a press release announcing the resumption of trading after a major offering, CAP is highly relevant, but RNS serves as the broad category for non-standard regulatory communications. Since the document is a press release announcing a market event (resumption of trading after an offering), and not the detailed offering document itself, RNS is a safe classification, though CAP is also plausible. I will lean towards RNS as it is a general regulatory announcement about market status, which often falls under this catch-all for non-standard filings, or CAP if the focus is strictly on the financing aspect. The text heavily implies a recent financing event (global offering). I will classify it as CAP due to the explicit mention of the 'offre globale' and the trading commencement on Nasdaq, which are financing/capital structure events.
2020-12-11 French
Inside Information / Operations of the issuer (acquisitions, sales...)
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "*PRESS RELEASE*" and announces the resumption of trading for Nanobiotix's ordinary shares following a halt related to a 'global offering'. It discusses the listing of American Depositary Shares (ADSs) on Nasdaq and references regulatory filings (Universal Registration Document filed with the AMF). This type of announcement, detailing corporate actions related to capital markets (trading resumption after an offering/listing event), is a general corporate event announcement. It is not a full financial report (10-K, IR), an earnings release (ER), a proxy statement (DEF 14A), or a specific capital change like a share repurchase (POS). Since it is a press release detailing a significant corporate event related to securities trading and capital structure changes (the completion of the offering), it fits best under Capital/Financing Update (CAP) or, if viewed as a general market announcement, Regulatory Filings (RNS). Given the context of the global offering completion and trading resumption, CAP is highly relevant, but the document itself is a general announcement about market mechanics. Since it is a press release announcing a corporate action related to financing/listing, and it doesn't fit the specific definitions of ER, DIV, or SHA, it is best classified as a general Regulatory Filing (RNS) or potentially CAP. However, RNS is the designated fallback for general regulatory announcements that don't fit elsewhere. Since the core event is the resumption of trading after a financing event, CAP is a strong candidate, but RNS covers general press releases about market status. Given the nature of the announcement (trading resumption following an offering), it is a significant corporate event announcement. I will classify it as RNS as it is a general regulatory announcement/press release about market status, which is often the catch-all for non-standard filings, although CAP is related to the underlying cause (the offering). Upon review, RNS is the most appropriate general category for press releases detailing market/trading status updates that aren't explicitly financial results or dividend notices.
2020-12-11 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.